Saturday 17 October 2026 Export INDV’s income statement to Excel — free account

Indivior Pharmaceuticals Inc.

INDV Healthcare Drug Manufacturers Specialty & Generic

Indivior Pharmaceuticals Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 4.29% from fiscal 2024. In the quarter to June 2026, revenue grew 13.6%, EPS grew 580.0%, free cash flow grew 58.6% and total debt rose 49.4%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.

32.45 1.17 −3.48%

Follow INDV

Alert me

Market cap: $4.0B
P/E: 11.2×
Fwd P/E: 11.8×
Dividend yield: 0.00%
F-score: 4/9
Altman Z: 3.28
Beneish M: −1.52
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	7	4	5	4
ROE Full definition →		(68.45%)	(96.33%)	(117.21%)	(153.12%)
ROA Full definition →		8.89%	16.69%	19.60%	26.52%
ROIC Full definition →		0.00%	629.81%	124.25%	460.53%
Return on Tangible Assets Full definition →		158.02%	(177.97%)	560.00%	1,873.68%
Average Days of Receivables Full definition →		84.14	75.12	80.64	78.70
Free Cash Flow per Share Full definition →		0.94	(0.76)	(1.55)	(0.93)
Free Cash Flow Full definition →		117.00	(95.00)	(192.00)	(111.00)
Capital Expenditures Full definition →		(60.00)	(68.00)	(81.00)	(71.00)
Other line items
Cash ROIC Full definition →		20.89%	(22.84%)	(37.14%)	(22.16%)
Accounts Receivable Turnover Full definition →		4.35	4.57	4.63	5.02
Accounts Payable Turnover Full definition →		0.44	1.06	1.34	1.19
Inventory Turnover Full definition →		1.36	1.54	1.54	1.61
Average Days of Payables Full definition →		345.70	370.94	268.47	313.29
Days of Inventory on Hand Full definition →		249.23	227.01	229.26	228.13
Tax Rate Full definition →		(0.34)	(0.12)	(0.15)	(0.10)
Research and Development Expense of Revenue Full definition →		9.07%	7.83%	7.05%	6.16%
Selling, General and Administrative Expense of Revenue Full definition →		52.63%	51.17%	48.45%	44.25%
Share Based Compensation of Revenue Full definition →		2.29%	2.10%	2.25%	2.40%
Interest Coverage Full definition →		4.45	5.82	8.30	15.56
Operating CF/Net income Full definition →		1.38	(0.13)	(0.44)	(0.11)
Depreciation/Fixed assets Full definition →		0.19	0.14	0.12	0.10
Capex/Depreciation Full definition →		(2.50)	(3.40)	(4.26)	(4.18)
Revenue per Share Full definition →		9.44	9.91	10.40	11.18
Operating CF per Share Full definition →		1.42	(0.22)	(0.90)	(0.34)
Capex per Share Full definition →		(0.48)	(0.54)	(0.65)	(0.60)
Capex to Sales Full definition →		0.05	0.05	0.06	0.05

Fold the line items

Columns are period end dates · fundamentals updated 2 Oct 2026

Stockrow Weekly